These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23049179)

  • 1. Intellectual property rights and patents in perspective of Ayurveda.
    Chaudhary A; Singh N
    Ayu; 2012 Jan; 33(1):20-6. PubMed ID: 23049179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
    Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic principles of pharmaceutical science in Ayurvĕda.
    Subhose V; Srinivas P; Narayana A
    Bull Indian Inst Hist Med Hyderabad; 2005; 35(2):83-92. PubMed ID: 17333665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global challenges of graduate level Ayurvedic education: A survey.
    Patwardhan K; Gehlot S; Singh G; Rathore HC
    Int J Ayurveda Res; 2010 Jan; 1(1):49-54. PubMed ID: 20532099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use and safety of non-allopathic Indian medicines.
    Gogtay NJ; Bhatt HA; Dalvi SS; Kshirsagar NA
    Drug Saf; 2002; 25(14):1005-19. PubMed ID: 12408732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patents and the supply of therapeutic products.
    Hayhurst WL
    Law Med Health Care; 1992; 20(3):235-7. PubMed ID: 1434767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of world health organization in the global acceptance of Ayurveda.
    Chaudhary A; Singh N
    J Ayurveda Integr Med; 2011 Oct; 2(4):179-86. PubMed ID: 22253507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
    Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
    Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ayurveda-modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis.
    Chopra A; Saluja M; Tillu G
    J Ayurveda Integr Med; 2010 Jul; 1(3):190-8. PubMed ID: 21547047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products.
    Kartal M
    Phytother Res; 2007 Feb; 21(2):113-9. PubMed ID: 17117452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A compilation of bioactive compounds from Ayurveda.
    Samy RP; Pushparaj PN; Gopalakrishnakone P
    Bioinformation; 2008; 3(3):100-10. PubMed ID: 19238245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual property rights: An overview and implications in pharmaceutical industry.
    Saha CN; Bhattacharya S
    J Adv Pharm Technol Res; 2011 Apr; 2(2):88-93. PubMed ID: 22171299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent law in dentistry: an overview.
    Bijle MN
    Indian J Dent Res; 2011; 22(4):574-9. PubMed ID: 22124055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines.
    Mukherjee PK; Wahile A
    J Ethnopharmacol; 2006 Jan; 103(1):25-35. PubMed ID: 16271286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements.
    Castro A; Westerhaus M
    Cad Saude Publica; 2007; 23 Suppl 1():S85-96. PubMed ID: 17308722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on access to medicines from TRIPS-Plus: a case study of Thai-US FTA.
    Kessomboon N; Limpananont J; Kulsomboon V; Maleewong U; Eksaengsri A; Paothong P
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):667-77. PubMed ID: 20578557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodiversity, biopiracy and benefits: what allegations of biopiracy tell us about intellectual property.
    Hamilton C
    Dev World Bioeth; 2006 Dec; 6(3):158-73. PubMed ID: 17038007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.